Precision Therapeutics Inc
Change company Symbol lookup
Select an option...
AIPT Precision Therapeutics Inc
SPN Superior Energy Services Inc
PVTL Pivotal Software Inc
NOV National Oilwell Varco Inc
SCS Steelcase Inc
PRTK Paratek Pharmaceuticals Inc
ASPU Aspen Group Inc
AFBA Allied First Bancorp Inc
G Genpact Ltd
WSGF World Series of Golf Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile

Precision Therapeutics Inc., formerly Skyline Medical Inc., is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed. The Company also manufactures and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap, and a single use bottle of cleaning solution. Both items are used on a single procedure basis. Its STREAMWAY Automated Surgical Fluid Waste Management System (FMS) is a wall mounted automated system that disposes of an unlimited amount of suctioned fluid from the patient using standard surgical tubing.

Day's Change
0.0069 (1.00%)
B/A Size
Day's High
Day's Low

Today's volume of 609 shares is on pace to be much lighter than AIPT's 10-day average volume of 45,130 shares.


Huawei arrest creates concerns in Silicon Valley as well as abroad

9:20 pm ET December 6, 2018 (MarketWatch)

By Therese Poletti, MarketWatch

Detainment of Huawei CFO creates concerns for U.S. suppliers as well as clouds trade dispute with China

The arrest of Huawei Technologies Co.'s chief financial officer is sure to put a crimp in the Trump administration's trade truce with China, as that highly sensitive issue gets more so, but investors are nervous about the impact the whole saga will have on Silicon Valley and abroad.

On Thursday, shares of many chip and fiber-optic companies fell, helping fuel a market downdraft that reversed at the end of the session ( Investors fear -- with good reason -- that the arrest in Canada of Meng Wanzhou, the CFO and the daughter of the founder of one of China's largest tech giants (, on a request for extradition from the United States, will derail the trade truce that presidents Donald Trump and Xi Jingping had agreed to in Buenos Aires. On Wednesday, a former Commerce Department official told Axios that China could retaliate ( hold U.S tech executives hostage. He advised U.S. tech executives not to travel to China this week.

"My biggest worry is escalation," said Stacy Rasgon, a Bernstein Reseach analyst. "We just arrested the daughter of the founder of the most important tech company in China."

Another cause for jitters is the possibility of a ban on Huawei products, and its impact not just on the global supply chain, but also on the many semiconductor firms that supply chips to Huawei for its smartphones and networking equipment. Stocks of chip makers such as Intel Corp. (INTC) , AMD Inc. (AMD) , Nvidia Corp. (NVDA), NXP Semiconductors N.V. (NXPI) and Xilinx Inc. (XLNX) fell in morning trading, but mostly recovered by the end of the day.

In addition, stocks of optical component vendors, such as Finisar Corp. (FNSR), Oclaro Inc. (OCLR) and Lumentum Holdings Inc. (LITE) , were also initially hit but later recovered. Their components are found in Huawei networking equipment, which had 28% of the world's telecom-equipment market in the third quarter, according to the Dell'Oro Group.

"Naturally, this has sparked a wave of questions as to Huawei exposure amongst our companies, especially given what happened with the ZTE ban earlier in the year," Rasgon said.

He noted that Huawei is "a sizeable buyer" of semiconductors, buying about $15 billion in 2017, according to Gartner Inc., and it is the fifth-largest buyer globally, accounting for about 3.5% of the market.

"If there were to be a ban on sales to Huawei, eventually business that Huawei could not supply would presumably go elsewhere, and our companies tend to have wider exposure. Hence 'lost' business would likely not be permanent," Rasgon said.

He added, though, that in the near term there could be some disruptions as supply chains are forced to evolve, which is what happened during the ban on buying products ( made by China's ZTE Corp. (000063.SZ) , which like Huawei was accused by the U.S. of violating sanctions against Iran.

But as investors worry about the latest Huawei news and its potential impact on individual companies, the bigger fear is its impact on the ongoing trade war. If anything, the latest news shows that Chinese companies will probably continue to operate by their own rules to increase their global power. This latest incident of another company selling products to Iran, against U.S. sanctions, is another blatant example.

Trump may think he alone can fight China's quest for world domination, but it might be time to work with some other countries whose businesses face the same risks.

-Therese Poletti; 415-439-6400;

(END) Dow Jones Newswires

December 06, 2018 21:20 ET (02:20 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.